CBAK Energy Technology released its second-quarter results, indicating that the transition to 40135 cells at the Dalian facility continues to impact results as expected. The company's Nanjing facility continues to operate at full capacity, and the expansion of that facility has been delayed due to challenges in securing the necessary equipment. The company is working with customers to navigate the new tariff landscape. Still, as negotiations between China and the US continue, the company is holding off on international expansion plans for the time being. The company's raw material business outperformed our expectations, and we are now forecasting roughly break-even results from this division for the foreseeable future.

19 Aug 2025
CBAT: The battery cell business remains challenging in 2025, but a substantial capacity upgrade is looming.

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
CBAT: The battery cell business remains challenging in 2025, but a substantial capacity upgrade is looming.
- Published:
19 Aug 2025 -
Author:
Brian Lantier -
Pages:
9 -
CBAK Energy Technology released its second-quarter results, indicating that the transition to 40135 cells at the Dalian facility continues to impact results as expected. The company's Nanjing facility continues to operate at full capacity, and the expansion of that facility has been delayed due to challenges in securing the necessary equipment. The company is working with customers to navigate the new tariff landscape. Still, as negotiations between China and the US continue, the company is holding off on international expansion plans for the time being. The company's raw material business outperformed our expectations, and we are now forecasting roughly break-even results from this division for the foreseeable future.